The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase
Open accessAbstract
The clinical benefit of the human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) is limited by the rapid selection of inhibitor-resistant viral variants. However, it may be possible to enhance the clinical utility of this inhibitor class by deriving compounds that express both high levels of antiviral activity and an augmented pharmacokinetic profile. Accordingly, we developed a new class of NNRTIs, the 1, 4-dihydro-2H-3, 1-benzoxazin-2-ones. L-743, 726 (DMP-266), a member of this class, was chosen for clinical evaluation because of its in vitro properties. The compound was a potent inhibitor of the wild-type HIV-1 RT (Ki = 2.93 nM) and exhibited a 95% inhibitory concentration of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture. In addition, L-7743, 7726 was found to be capable of inhibiting, with 95% inhibitory concentrations of < or = 1.5 microM, a panel of NNRTI-resistant mutant viruses, each of which expressed a single RT amino acid substitution. Derivation of virus with notably reduced susceptibility to the inhibitor required prolonged cell culture selection and was mediated by a combination of at least two RT amino acid substitutions. Studies of L-743, 726 in rats, monkeys, and a chimpanzee demonstrated the compound's potential for good oral bioavailability and pharmacokinetics in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phase annealing in SHELX-90: direct methods for larger structures
Sheldrick, G. M. (1990) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390000277 · Cited by 16,288
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors
Spence, R. A., Kati, W. M., Anderson, K. S., & Johnson, K. A. (1995) · Science · doi:10.1126/science.7532321 · Cited by 522
Tantillo, C., Ding, J., Jacobo-Molina, A., Nanni, R. G., Boyer, P. L., Hughes, S. H., Pauwels, R., Andries, K., Janssen, P. A. J., & Arnold, E. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1665 · Cited by 518
Nunberg, J. H., Schleif, W. A., Boots, E. J., O'Brien, J. A., Quintero, J. C., Hoffman, J. M., Emini, E. A., & Goldman, M. E. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4887-4892.1991 · Cited by 363
Smerdon, S. J., Jäger, J., Wang, J., Kohlstaedt, L. A., Chirino, A. J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3911 · Cited by 331
Studies on liver alcohol dehydrogenase complexes
Yonetani, T., & Theorell, H. (1964) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(64)90184-5 · Cited by 280
Goldman, M. E., Nunberg, J. H., O'Brien, J. A., Quintero, J. C., Schleif, W. A., Freund, K. F., Gaul, S. L., Saari, W. S., Wai, J. S., & Hoffman, J. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6863 · Cited by 279
Wu, J. C., Warren, T. C., Adams, J., Proudfoot, J., Skiles, J., Raghavan, P., Perry, C., Potocki, I., Farina, P. R., & Grob, P. M. (1991) · Biochemistry · doi:10.1021/bi00222a003 · Cited by 180
Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E.
Althaus, I. W., Chou, J. J., Gonzales, A. J., Deibel, M. R., Chou, K. C., Kezdy, F. J., Romero, D. L., Aristoff, P. A., Tarpley, W. G., & Reusser, F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53227-0 · Cited by 163
Saag, M. S., Emini, E. A., Laskin, O. L., Douglas, J. A., Lapidus, W. I., Schleif, W. A., Whitley, R. J., HILDEBRAND, C. S., Byrnes, V. W., Kappes, J. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310073291502 · Cited by 156
Sardana, V. V., Emini, E. A., Gotlib, L., Graham, D. J., Lineberger, D. W., Long, W. J., Schlabach, A. J., Wolfgang, J., & Condra, J. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37074-7 · Cited by 112
Byrnes, V. W., Sardana, V. V., Schleif, W. A., Condra, J. H., Waterbury, J. A., Wolfgang, J., Long, W. J., Schneider, C. L., Schlabach, A. J., & Wolanski, B. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1576 · Cited by 106
Tucker, T. J., Lyle, T. A., Wiscount, C. M., Britcher, S. F., Young, S. D., Sanders, W. M., Lumma, W. C., Goldman, M. E., O'Brien, J. A., & Ball, R. G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00041a023 · Cited by 76
Self-citationDueweke, T. J., Kézdy, F. J., Waszak, G. A., Deibel, M. R., & Tarpley, W. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48451-7 · Cited by 63
Frank, K. B., Noll, G. J., Connell, E. V., & Sim, I. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98672-2 · Cited by 48
Non-nucleoside inhibitors of HIV-1 reverse transcriptase
Young, S. D. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171661 · Cited by 47
Self-citationCarroll, S. S., Olsen, D. B., Bennett, C. D., Gotlib, L., Graham, D. J., Condra, J. H., Stern, A. M., Shafer, J. A., & Kuo, L. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54146-6 · Cited by 43
Self-citationCarroll, S. S., Stahlhut, M. W., Geib, J., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31642-9 · Cited by 18
Self-citation
Cited by
Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway
Brinkman, K., ter Hofstede, H. J. M., Burger, D. M., Smeitink, J. A. M., & Koopmans, P. P. (1998) · AIDS · doi:10.1097/00002030-199814000-00004 · Cited by 847
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Wang, J., Morin, P., Wang, W., & Kollman, P. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003834q · Cited by 708
Recent advances in the trifluoromethylation methodology and new CF3-containing drugs
Zhu, W., Wang, J., Wang, S., Gu, Z., Aceña, J. L., Izawa, K., Liu, H., & Soloshonok, V. A. (2014) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2014.06.026 · Cited by 493
Metadata
- Authors
- Young, S. D., Britcher, S. F., Tran, L. O., Payne, L. S., Lumma, W. C., Lyle, T. A., Huff, J. R., Anderson, P. S., Olsen, D. B., & Carroll, S. S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1995-12
- Volume
- 39
- Issue
- 12
- Pages
- 2602-2605
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2161558889
- Cited by
- 482
- References
- 19
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.